3 Patents
- US119577602024Folate Receptor Targeted Nanoparticle Drug Conjugates and Uses Thereof
Elucida Oncology, Inc.
0 cites - US119256292024Heterocyclic Inhibitors of ERK1 and ERK2 and Their Use in the Treatment of Cancer
ASANA BIOSCIENCES, LLC
0 cites - US117448972023Folate Receptor Targeted Nanoparticle Drug Conjugates and Uses Thereof
Elucida Oncology, Inc.
0 cites